Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-286833
Filing Date
2020-11-05
Accepted
2020-11-05 16:13:59
Documents
78
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d52920d10q.htm   iXBRL 10-Q 2163896
2 EX-10.1 d52920dex101.htm EX-10.1 57184
3 EX-31.1 d52920dex311.htm EX-31.1 11233
4 EX-31.2 d52920dex312.htm EX-31.2 11215
5 EX-32.1 d52920dex321.htm EX-32.1 4297
6 EX-32.2 d52920dex322.htm EX-32.2 4279
  Complete submission text file 0001193125-20-286833.txt   8035258

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA tbio-20200930.xsd EX-101.SCH 59371
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tbio-20200930_cal.xml EX-101.CAL 46586
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tbio-20200930_def.xml EX-101.DEF 298236
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE tbio-20200930_lab.xml EX-101.LAB 495073
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tbio-20200930_pre.xml EX-101.PRE 422461
12 EXTRACTED XBRL INSTANCE DOCUMENT d52920d10q_htm.xml XML 1163952
Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 29 HARTWELL AVENUE LEXINGTON MA 02421 617-945-7361
Translate Bio, Inc. (Filer) CIK: 0001693415 (see all company filings)

EIN.: 611807780 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38550 | Film No.: 201290600
SIC: 2836 Biological Products, (No Diagnostic Substances)